Tag: cancer_vaccines

Media Monitor: New mRNA Adjuvant Boosts Vaccine Efficacy for Cancer and Infectious Diseases

25 Aug 2026 5:00 p.m. · Source: MIT Technology Review

MIT Technology Review reports on a new mRNA adjuvant developed by MIT, Harvard, and University of Houston researchers that significantly enhances the immune response to cancer and infectious disease vaccines.

Health Science & Technology Medical Science Education Nanotechnology mRNA Adjuvant Cancer Vaccines Infectious Diseases T-cells MIT Polio MIT Technology Review science technology